MIRA INFORM REPORT

 

 

Report No. :

317507

Report Date :

15.04.2015

 

IDENTIFICATION DETAILS

 

Name :

MEDISPRAY LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

Plot No. 344/345, Kundaim Industrial Estate, Kundaim – 403115, Goa

Tel. No.:

91-832-2395656

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

21.02.1992

 

 

Com. Reg. No.:

24-002801

 

 

Capital Investment / Paid-up Capital :

Rs.0.510 Million

 

 

CIN No.:

[Company Identification No.]

U52311GA1992PTC002801

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACM4153B

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in Pharmaceuticals Bulk Drugs Like Tablets, Capsules, Aerosols, etc.

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (67)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of Meditab Specialities Private Limited. It is a well- established company having fine track record.

 

Financial position of the company seems to be strong. Overall fundaments of the company seems to be sound and healthy.

 

Directors are reported to be experienced and respectable businessmen.

 

Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DENIED

 

UNABLE TO CONTACT (91-832-2395656 / 2395184 CONTINUOUSLY RINGING)

 

 

LOCATIONS

 

Registered Office :

Plot No. 344/345, Kundaim Industrial Estate, Kundaim - 403115, Goa, India 

Tel. No.:

91-832-2395656/2395184

Fax No.:

Not Available

E-Mail :

medispray.labs@indiatimes.com

 

 

DIRECTORS

 

As on 11.09.2013

 

Name :

Mr. Rajesh Dinkar Sawant

Designation :

Whole Time Director

Address :

14, Okasa Residential Complex, Friends Colony, Kharpabadh, Ponda-403401, Goa, India

Date of Birth/Age :

23.12.1967

Date of Appointment :

01.12.2005

Din No.:

00380168

 

 

Name :

Mr. Ijaj Abdulgani Khalif

Designation :

Director

Address :

F-1, Salfumiua Apartment, Near PWD Fatorda, Margao-403602, Goa, India

Date of Birth/Age :

31.05.1968

Date of Appointment :

01.10.2010

Din No.:

00347230

 

 

Name :

Mr. Ramanujam Narayanan Ananthakrishnapuram

Designation :

Director

Address :

B-4/10, Manav Kalyan Society, Bangur Nagar, Goregaon (West), Mumbai-400090, Maharashtra, India

Date of Birth/Age :

04.06.1966

Date of Appointment :

04.11.2011

Din No.:

00017935

 

 

 

MAJOR SHAREHOLDERS

 

As on 11.09.2013

 

Names of Shareholders

 

No. of Shares

Meditab Specialities Private Limited, India

51014

Hamied K Mustafa Jointly With Meditab Specialities Private Limited, India

1

Hamied M Kamil Jointly With Meditab Specialities Private Limited, India

1

S Radhakrishnan Jointly With Meditab Specialities Private Limited, India

1

R. Gopalakrishnan Jointly With Meditab Specialities Private Limited, India

1

Sanghvi Arvind Mital Jointly With Meditab Specialities Private Limited, India

1

Athipotta Parameswaran Raman Jointly With Meditab Specialities Private Limited, India

1

 

 

Total

51020

 

As on 11.09.2013

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Bodies corporate

100.00

Total

100.00

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in Pharmaceuticals Bulk Drugs Like Tablets, Capsules, Aerosols, etc.

 

 

Products :

PRODUCT DESCRIPTION

ITEM CODE

 

Amoxicillin

300410.30

Formulation (Aerosol)

294200

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

 

GENERAL INFORMATION

 

Suppliers :

Not Divulged

 

 

Customers :

Not Divulged

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

Not Divulged

 

 

 

Banking Relations :

---

 

 

Auditors :

 

Name :

V. Sankar Aiyer and Company

Chartered Accountants

Address :

2-C, Court Chambers, 35 New Marine Lines, Mumbai – 400020, Maharashtra, India

PAN No.:

AAAFV0781D

 

 

Ultimate Holding Company :

Cipla Limited

 

 

Holding Company :

Meditab Specialities Private Limited

 

 

Fellow Subsidiary Company :

  • Sitec Labs Private Limited
  • Goldencross Pharma Private Limited
  • Cipla (Mauritius) Limited
  • Cipla (UK) Limited
  • Cipla Australia Pty. Limited
  • Cipla (EU) Limited
  • Four M Propack Private Limited
  • Meditab Holdings Limited
  • Meditab Pharmaceuticals South Africa (Pty) Limited
  • Meditab Specialities New Zealand Limited
  • Cipla Ilac Ticaret Anonim Sirketi
  • Cipla USA Inc.
  • Cipla Kenya Limited
  • Cipla Malaysia Sdn. Bhd.
  • Cipla Medpro South Africa (Pty) Limited
  • Cipla Holding B.V.
  • Cipla Europe NV
  • Cipla Quality Chemical Industries Limited (formerly Quality Chemical Industries Limited)
  • Celeris d.o.o.
  • Cipla Medpro Manufacturing Proprietary Limited
  • Inyanga Trading 386 Proprietary Limited
  • Xeragen Laboratories Proprietary Limited
  • Cipla Medpro Holdings Proprietary Limited
  • Cape to Cairo Exports Proprietary Limited
  • Cipla Agrimed Proprietary Limited
  • Cipla Dibcare Proprietary Limited
  • Cipla Health Care Proprietary Limited
  • Cipla Life Sciences Proprietary Limited
  • Cipla-Medpro Proprietary Limited
  • Cipla-Medpro Distribution Centre Proprietary Limited
  • Cipla Medpro ARV Proprietary Limited
  • Cipla Medpro Botswana Proprietary Limited
  • Cipla Medpro Cardio Respiratory Proprietary Limited
  • Cipla Medpro Research and Development Proprietary Limited
  • Cipla Nutrition Proprietary Limited
  • Cipla Personal Care Proprietary Limited
  • Cipla Vet Proprietary Limited
  • Gardian Cipla Proprietary Limited
  • Medpro Gen Proprietary Limited
  • Medpro Holdings Proprietary Limited
  • Medpro Pharmaceutica Proprietary Limited
  • Medpro Pharmaceutica Africa Proprietary Limited
  • Medpro-On-Line Proprietary Limited
  • Med Man Care Proprietary Limited
  • Smith and Couzin Proprietary Limited

 

 

 

 

 

 

 

CAPITAL STRUCTURE

 

As on 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

100000

Equity Shares

Rs.10/- each

Rs.1.000 Million

500000

Preferences Shares

Rs.100/- each

Rs.50.000 Million

 

 

 

 

 

TOTAL

 

Rs.51.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

51020

Equity Shares

Rs.10/- each

Rs.0.510 Million

 

 

 

 

 

 


FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

0.510

0.510

0.510

(b) Reserves & Surplus

822.090

603.480

411.272

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

822.600

603.990

411.782

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.476

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

4.875

4.722

2.923

Total Non-current Liabilities (3)

4.875

4.722

3.399

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

128.669

133.176

60.770

(c) Other current liabilities

5.180

43.243

22.583

(d) Short-term provisions

0.305

0.764

0.376

Total Current Liabilities (4)

134.154

177.183

83.729

 

 

 

 

TOTAL

961.629

785.895

498.910

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

57.302

57.581

60.408

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

6.724

6.413

5.114

(iv) Intangible assets under development

2.070

0.000

0.000

(b) Non-current Investments

2.751

2.896

3.048

(c) Deferred tax assets (net)

0.669

0.522

0.000

(d)  Long-term Loan and Advances

89.224

92.834

133.002

(e) Other Non-current assets

12.723

2.386

7.604

Total Non-Current Assets

171.463

162.632

209.176

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

520.954

269.423

26.094

(b) Inventories

81.085

114.543

61.067

(c) Trade receivables

95.231

142.009

179.033

(d) Cash and cash equivalents

8.667

17.421

14.530

(e) Short-term loans and advances

84.229

79.867

9.010

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

790.166

623.263

289.734

 

 

 

 

TOTAL

961.629

785.895

498.910

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

 

 

 

Other Income

 

 

 

 

 

TOTAL            

721.117

757.139

497.465

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL            

409.053

465.930

333.936

 

 

 

 

 

 

PROFIT BEFORE TAX

312.064

291.209

163.529

 

 

 

 

 

Less

TAX                                         

93.454

99.001

52.652

 

 

 

 

 

 

PROFIT AFTER TAX

218.610

192.208

110.877

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

499.299

307.091

196.214

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

717.909

499.299

307.091

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

483.399

525.532

160.621

 

 

 

 

 

 

Earnings Per Share (Rs.)

4285.00

3767.31

217.21

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Return on Total Assets

(PBT/Total Assets}

(%)

32.87

37.52

33.32

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.38

0.48

0.40

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

5.89

3.52

3.46

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

0.510

0.510

0.510

Reserves & Surplus

411.272

603.480

822.090

Net worth

411.782

603.990

822.600

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Total Income

497.465

757.139

721.117

 

 

52.199

(4.758)

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Total Income

497.465

757.139

721.117

Profit

110.877

192.208

218.610

 

22.29%

25.39%

30.32%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

NOTE: CURRENT MATURITIES OF LONG TERM DEBTS IS NOT AVAILABLE

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

No

24]

Banking facility details

No

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGES: NO CHARGES EXIST FOR THE COMPANY

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Plant and equipment
  • Furniture and Fixtures
  • Office equipment

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.39

UK Pound

1

Rs.91.06

Euro

1

Rs.66.16

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

NKT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILITY

1~10

8

--LIQUIDITY

1~10

8

--LEVERAGE

1~10

8

--RESERVES

1~10

8

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

NO

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

67

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.